Presentation - The EU EU health policy Pharmaceutical Reform - Lilia Luchianov (DG SANTE, EC)
Guideline on specific adverse reaction follow-up questionnaires (Specific AR FUQ)
Proposed invented name(s) request form for veterinary medicinal products
Quality Review of Documents (QRD) working group plenary meeting dates
Norditropin (somatropin) supply shortage
CTIS newsflash – 24 November 2023
Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 10, Status: Authorised
Agenda of the CVMP meeting 5-7 December 2023
Human medicines European public assessment report (EPAR): Trajenta, linagliptin, Date of authorisation: 23/08/2011, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Relistor, methylnaltrexone bromide, Date of authorisation: 01/07/2008, Revision: 19, Status: Authorised